Viveve Medical (VIVE) Receives Approval for Viveve System in U.A.E., Lebanon

October 13, 2016 4:03 PM EDT
Get Alerts VIVE Hot Sheet
Trade VIVE Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Viveve Medical, Inc. (Nasdaq: VIVE) announced that the company has received regulatory approvals for the Viveve System in the United Arab Emirates (U.A.E.) and Lebanon. The Viveve System is now cleared for marketing in 47 countries throughout the world.

"U.A.E. and Lebanon represent very important markets for Viveve and the regulatory approvals of the Viveve System in these countries are significant developments. In partnership with our distribution partner, Medica Group, we have begun the commercialization efforts for the Viveve System in the Middle East to make this clinically-proven treatment available to women in the region whose quality of life is impacted by vaginal laxity," said Patricia Scheller, chief executive officer of Viveve.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment